{"cdcTestId":"2021-0031","testcaseName":"Patient is 20 years of age and was administered Pfizer\u0027s Vaccine 5-11 formulation as a second dose","vaccineGroup":"COVID-19","evaluationTestType":"Vaccine: Invalid Usage","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2001-12-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-05-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Inadvertent Vaccine"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-10-19T00:00:00","recommendedDate":"2022-10-19T00:00:00","pastDueDate":"2022-10-19T00:00:00"},"doses":[{"dateAdministered":"2022-05-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"218","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Inadvertent Vaccine"}],"dateAdded":"2021-11-04T20:00:00","dateUpdated":"2022-01-11T08:56:11.383","generalDescription":"This test case describes when a patient who is 18 years or older and is administered Pfizer\u0027s vaccine for 5-11 years formulation as a second dose that the dose is considered not valid and an age appropriate dose should be re-administered immediately (repeat dose).","changedInVersion":"4.18","reasonForChange":"v4.18 Updated past due date.\nv4.15 Added a past due date."}